Our immuno precipitation experimentspresent evidence that, treatment of glioma cells with hUCBSC leads to thearrest of cell-cycle progression through inactivation of both cyclin D1/Cdk4 and cyclin D1/Cdk 6 complexes. This evidence concerns the gene CDK4 and central nervous system cancer.